Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iqvia Holdings Inc
(NY:
IQV
)
201.82
+4.22 (+2.14%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iqvia Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
IQVIA Reports Second-Quarter 2024 Results
July 22, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
How Is The Market Feeling About IQVIA Hldgs?
July 19, 2024
Via
Benzinga
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
July 11, 2024
From
IQVIA
Via
Business Wire
IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
July 08, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
5 Analysts Assess IQVIA Hldgs: What You Need To Know
June 28, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For IQVIA Hldgs
June 06, 2024
Via
Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
June 04, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 01, 2024
Via
Benzinga
IQVIA’s SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
June 25, 2024
From
IQVIA
Via
Business Wire
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
June 12, 2024
From
IQVIA
Via
Business Wire
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
June 10, 2024
From
IQVIA
Via
Business Wire
Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs
May 03, 2024
Via
Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
March 29, 2024
Via
Benzinga
Peering Into IQVIA Hldgs's Recent Short Interest
March 13, 2024
Via
Benzinga
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
June 07, 2024
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 17, 2024
Via
Benzinga
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
May 14, 2024
From
IQVIA
Via
Business Wire
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
May 09, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
IQV stock results show that IQVIA Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
IQVIA Reports First-Quarter 2024 Results
May 02, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
Analysts Are Pounding the Table on These 3 Stocks: April 2024
May 01, 2024
From pharmaceutical testing to expansive integration expanding infrastructure, here are three stocks with analyst recommendations to buy.
Via
InvestorPlace
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
April 23, 2024
From
IQVIA
Via
Business Wire
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
April 15, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
April 09, 2024
Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement.
Via
Benzinga
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
April 08, 2024
From
IQVIA
Via
Business Wire
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
March 06, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Publishes its 2023 Environmental, Social and Governance Report
February 26, 2024
From
IQVIA
Via
Business Wire
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
February 23, 2024
From
IQVIA
Via
Business Wire
IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024
February 21, 2024
From
IQVIA Holdings Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.